FDA答复函的要点是，在监管机构继续审评之前本药物需要更多的临床试验。
The main gist of the FDA response was that the drug requires more trials before the Agency could proceed .
我们在等待你早日答复这一询函。
We are expecting to receive your earliest reply to this enquiry .
答复函